Neoplasm Treatment Market : Current Analysis and Forecast (2022-2028)
$3999 – $6999
Emphasis on Type (Malignant and Benign); Treatment Type (Surgery, Chemotherapy, Targeted Therapy, and Others); End-User (Hospitals, Cancer Research Center, Specialty Clinics, And Others); Region (North America, Europe, Asia-Pacific, Rest of the World); and Region/Country
The global neoplasm treatment market is expected to grow at a significant rate of around 8% during the forecast period. Neoplasm refers to the abnormal growth of tissue caused by the rapid division of cells that have undergone some form of mutation. In this condition, the group of cells grows in an uncoordinated manner with the surrounding cells and can cause damage to the tissues surrounding them. The rising geriatric population and high risk of cancer in old-aged attributes to the growth of the neoplasm treatment market. For instance, according to the World Health Organization, by 2030, 1 in 6 people in the world will be aged 60 years or over and by 2050, the world’s population of people aged 60 years and older will double (2.1 billion).
Eisai Co., Ltd.; Exelixis, Inc.; Thermo Fisher Scientific; Boehringer Ingelheim International GmbH; Bayer AG; Abbott; Merck & Co., Inc.; Teva Pharmaceutical Industries Ltd; Siemens Healthcare GmbH.; and Novartis AG are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst Type, benign category to grow with the considerable rate during the forecast period.”
Based on the type, the market has been categorized into malignant and benign. Among them, the benign segment is expected to grow at a considerable rate in the market. Benign tumors are considered the most common form of the tumor and their rising number attributes to the growth of the segment. For instance, as per the office on women’s health, about 20 percent to 80 percent of women develop fibroids by the time they reach age 50. Fibroids are most common in women in their 40s and early 50s.
“Amongst Treatment Type, the chemotherapy segment held the dominant share in the market in 2020.”
Based on the treatment type, the market has been categorized into surgery, chemotherapy, targeted therapy, and others. Among them, the chemotherapy segment held the dominant share in 2020. Chemotherapy is more cost-efficient and minimally invasive procedure, which acts as a key factor responsible for its high adoption among cancer patients. Furthermore, the rising prevalence of oncological disorders and the increasing demand for cost-efficient treatment is also important to factor for the market growth of the segment.
Neoplasm Treatment Market Report Coverage
“Amongst End-User, specialty clinics segment to hold a higher CAGR during the forecast period”
Based on the end-user, the market has been categorized into hospitals, cancer research centers, specialty clinics, and others. Among them, the specialty clinics segment holds a higher CAGR during the forecast period. The rising prevalence of cancer and the favorable government policies along with the presence of specialized professionals in the specialty centers attributes to the growth of the segment in the market.
“Asia Pacific to witness the fastest growth in the market”
Asia-Pacific is anticipated to grow at the fastest rate during the forecast period. The major factors such as rising medical expenditure, increasing disposable income of people, along with continuously rising population of cancer patients in the region attributes to the market growth of neoplasm treatments in the region. For instance, according to the Indian Council of Medical Research (ICMR), the estimated number of people with cancer was around 2.7 million in 2020, and every year number of new cancer patients registered accounted for 13.9 lakhs.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
The global Neoplasm Treatment market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
You can also purchase parts of this report. Do you want to check out a section wise
|2.1.||Research Process of the Neoplasm Treatment Market|
|2.2.||Research Methodology of the Neoplasm Treatment Market|
|5||IMPACT OF COVID-19 ON THE NEOPLASM TREATMENT MARKET|
|6||NEOPLASM TREATMENT MARKET REVENUE (USD BN), 2020-2028F|
|9.2.||Cancer Research Center|
|10.1.3.||Rest of North America|
|10.2.6.||Rest of Europe|
|10.3.4.||Rest of Asia-Pacific|
|10.4.||Rest of World|
|12||NEOPLASM TREATMENT MARKET OPPORTUNITIES|
|13||NEOPLASM TREATMENT MARKET TRENDS|
|14.1.||Demand Side Analysis|
|14.2.||Supply Side Analysis|
|15||VALUE CHAIN ANALYSIS|
|16.1.1.||Porters Fiver Forces Analysis|
|17.1.||Eisai Co., Ltd.|
|17.3.||Thermo Fisher Scientific|
|17.4.||Boehringer Ingelheim International GmbH|
|17.7.||Merck & Co., Inc.|
|17.8.||Teva Pharmaceutical Industries Ltd|
|17.9.||Siemens Healthcare GmbH|
Research Methodology for the Neoplasm Treatment Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global neoplasm treatment market were the three major steps undertaken to create and analyze the adoption of neoplasm treatments in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global neoplasm treatment market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the neoplasm treatment market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the neoplasm treatment market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type, treatment type, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the neoplasm treatment market. Further, we conducted factor analysis using dependent and independent variables such as the type, treatment type, and end-user of neoplasm treatment. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the neoplasm treatment market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global neoplasm treatment market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the neoplasm treatment market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global neoplasm treatment market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global neoplasm treatment market. Data was split into several segments & sub-segments post studying various parameters and trends in the type, treatment type, and end-user in the global neoplasm treatment market.
The main objective of the Global Neoplasm Treatment Market Study
The current & future market trends of the global neoplasm treatment market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the neoplasm treatment market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of type, treatment type, and end-user.
- Define and analysis of the regulatory framework for the neoplasm treatment industry.
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
- Analyze the current and forecast market size of the neoplasm treatment market for the major region.
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World.
- Company profiles of the Neoplasm Treatment market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry